Module 1.3 (Medications and Breastfeeding) Flashcards
What are breastfeeding benefits for mother
- Assist in losing weight
- Reduce risk of T2DM, blood pressure and heart disease
- Lower rates of ovarian and breast cancer
- Promotes bonding
- Convenient
- Free
What are the breastfeeding benefits for baby?
- All nutritional requirements for growth and development
- Easier to digest
- Contains antibodies, immunoglobulins
- Reduces risk of infectious diseases
- Reduces risk of SIDS
96% new mothers initiate breastfeeding - 60% continue to 6 months. How many use medications?
- Majority need at least one medication
- Prescribed medication
- OTC
- Herbal and complementary medicines
- Illicit substances
What are general safety comments about medications in breastfeeding?
Most medications transfer into milk
Amount received by breastfed infant is LOW
Very few pose significant risk
What are some common medications that cause adverse drug reaction in breast milk in infants?
Opioids 25%
Antidepressants 15%
Multiple drug classes 11%
Anticonvulsants 11%
Iodine 6%
Antimicrobials 6%
Antipsychotics 4%
Cardiovascular drugs 4%
Sedatives 4%
What to do when treating breastfeeding mother?
- Treat mother effectively
- Minimise infant exposure
- Minimially disrupt nursing
Witholding breastfeeding is NOT a risk free option as mother and baby will be deprived of benefits
How does drug transfer into milk occur?
- Mainly - passive diffusion
- Gaps between alveolar cells
> early post natal period
> passage of immunoglobulins, maternal proteins
Factors affecting infant exposure?
- Drug properties
- Maternal facotrs
- Infant factors
Outline how the below drug properties affect infant exposure:
A) Protein binding
B) Molecular weight
C) Lipid solubility
D) Volume of distribution
E) Ionisation
A)
high (>90%)→ unable to diffuse into milk (ibuprofen, warfarin)
B)
<200da cross readily, 800-1000da may cross, >1000da unlikely
C)
Milk more lipophilic (benzodiazepines) cross more easily
D)
Drugs with high volumes of distribution (Vd) (1-20 L/kg) are distributed in higher concentrations in remote compartments of the body, and may not stay in the blood
E)
pKa measures pH at which drug is equally ionic and nonionic
The more ionic a drug, the less it can transfer from the milk to the plasma, so pKa>7.2 can be ion trapped in milk.
Outline how the below maternal factors affect infant exposure
A) Pharmacogenomics
B) Maternal bioavailability
C) Maternal plasma concentration
A)
Influenced by metabolism differences (codeine)
B)
Low bioavailability –> low plasma levels (pyrantel)
D)
Via passive diffusion (how drug gets into breast milk)
High plasma concentration = cross into breast milk more likely
E.g. sertraline has lower maternal plasma and high volume of distribution = lower in milk (sertraline)
Outline how the below infant factors affect infant exposure
A) Amount of drug ingested by infant
B) Oral bioavaliablilty in infant
C) Age of infant
D) Use in infants
A)
- Milk concentration
- Daily milk intake (150mL/kg/day)
B)
- Infant’s stomach acidity denatures many drugs (aminoglycosides, omeprazole)
C)
- Immature metabolism in preterm infants
D)
- If used therapeutically unlikely to be toxic via breastmilk
Clearance values (hepatic and renal) as baby ages
What is the formula for relative infant dose (RID)?
> better than M/P
Infant dose(mg/kg/day) / Maternal dose (mg/kg/day) x 100
< 10% is safe
What is the milk/plasma ratio (M/P)?
Use to calculate milk concentration if maternal plasma concentration known
How to do risk assessment of the infant through:
A) infant
B) drug
C) dose based on milk transfer
A)
age = premature and newborn at greater risk
size = calculate dose
stability = unstable infants may increase risk
B)
Paediatric use
Inherent toxicity
C)
What is the relative infant dose (RID). Less or more than 10%.
Infant dose –> compare this to therapeutic use
M/P